Lung AI vs EchoConfidence (USA)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Lung AI

by Multiple (e.g., RevealDx, Optellum, LungLife AI, Qure.ai, Arterys, DeepHealth, HeartLung.AI)

EchoConfidence (USA)

by EchoConfidence (USA)

AI Verdict

Lung AI offers a handheld ultrasound platform with integrated AI for real-time cardiac and lung scanning, focusing on immediate clinical decisions during image acquisition. EchoConfidence, conversely, is a software-only solution that analyzes pre-acquired transthoracic echocardiogram images to automate measurements and assist in report generation. While both utilize AI in cardiology, their distinct deployment models and primary points of intervention in the clinical workflow make them adjacent rather than direct competitors.

Choose Lung AI if…

Choose Lung AI if you require immediate, on-site diagnostic imaging and AI-powered assistance for lung and basic cardiac assessments. Its handheld form factor and on-device AI processing are ideal for point-of-care ultrasound in emergency departments, critical care settings, or remote locations where rapid decision-making and portability are paramount. This tool excels in situations demanding quick, real-time insights without reliance on external infrastructure.

View Lung AI →

Choose EchoConfidence (USA) if…

Choose EchoConfidence if your primary need is to enhance and streamline the detailed analysis of pre-acquired transthoracic echocardiogram images within a structured cardiology workflow. This AI-powered SaMD excels at automating over 100 complex cardiac measurements, classifying views, segmenting structures, and assisting in comprehensive report generation, thereby improving efficiency and consistency in a diagnostic lab setting. It is best suited for environments focused on in-depth, quantitative echo analysis and reporting.

View EchoConfidence (USA) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Lung AI	EchoConfidence (USA)
Deployment	Cloud-based, integrated with existing platforms (e.g., RapidAI), and potentially on-premise.	On-premise within the hospital's existing DICOM, PACS, and RIS infrastructure.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Lung AI

Tool A (Lung AI / Exo Iris) is designed for simplicity and immediate answers, integrating a handheld ultrasound with real-time AI and guided image capture (SweepAIu2122) to enable even novice users to get instant results. It also offers 'Exo U' for AI-powered POCUS education and training, significantly lowering the barrier to entry for a wider range of clinicians.

Clinical Value

Tie

Both tools offer significant clinical value, validated by FDA clearance and clinical studies. Tool A provides real-time, point-of-care diagnostics for lung and basic cardiac conditions, improving accuracy for a broad user base. Tool B delivers comprehensive, automated analysis of echocardiograms with over 100 measurements, offering deep insights for cardiac specialists.

Pricing & Value

EchoConfidence (USA)

While both tools lack transparent public pricing for enterprise solutions, Tool A has a disclosed hardware cost and mandatory annual subscription, making its overall cost more predictable but potentially higher for long-term use. Tool B, despite not having a public upfront price, has evidence suggesting it is cost-saving per scan due to reduced staff time, indicating a strong value proposition for efficiency within existing workflows.

Enterprise Readiness

Lung AI

Tool A explicitly states HITRUST, HIPAA, SOC2 Type II compliance, and ISO 27001 certification, providing a higher level of documented security and compliance assurance. Despite being an on-device solution, it offers robust integration capabilities with existing PACS, VNA, and EHR systems, along with secure cloud storage options, making it highly adaptable for enterprise deployment.

Innovation

Lung AI

Tool A's innovation lies in its disruptive approach to medical imaging by integrating high-performance AI directly into a handheld, internet-independent ultrasound device. This enables real-time, guided diagnostics at the point of care, fundamentally changing how and where ultrasound can be utilized.

Support & Docs

Lung AI

Tool A explicitly includes 'Exo U (AI-powered POCUS education and training)' as a key feature, demonstrating a direct commitment to user education and ongoing support. It also offers proficiency tracking, which is crucial for continuous competency development, a feature not explicitly mentioned for Tool B.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Lung AI	EchoConfidence (USA)
Name	Lung AI	EchoConfidence (USA)
Company	Exo	Mycardium AI Limited
Primary Application/Focus	High-performance, handheld ultrasound platform for imaging and therapeutic applications, focusing on cardiac and lung scanning.	AI-powered Software as a Medical Device (SaMD) for analyzing transthoracic echocardiogram images, automating measurements, and assisting in report generation.
Key AI-powered Detection/Analysis	AI-powered detection of pleural effusion, consolidation/atelectasis; automated AI-based indicators for cardiac conditions (e.g., heart failure, hypertrophy).	AI-powered transthoracic echocardiogram analysis; automatic view classification; segmentation of cardiac structures (ventricles, atria, walls, great vessels); measures of cardiac function.
Doppler Capabilities	Pulsed-wave Doppler capabilities (on Exo Iris)	Doppler assessments
On-device AI Processing	On-device AI processing (operates without internet)	Not specified
Education/Training Component	Exo U (AI-powered POCUS education and training)	Not specified
Human-in-the-loop AI	Not specified	Human-in-the-loop AI capabilities

Videos

Demos, reviews, and walkthroughs featuring Lung AI and EchoConfidence (USA).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for cardiac and lung assessments?

Lung AI by Exo is integrated directly into the Exo Iris handheld ultrasound device, providing real-time AI processing at the point of care without needing an internet connection. EchoConfidence, on the other hand, is software installed on a hospital's computer system, designed to connect with existing imaging systems like echocardiogram machines or PACS for post-acquisition analysis and report generation.

Beyond cardiology, which specific specialties or use cases are best served by each tool's AI capabilities?

Lung AI by Exo is particularly suited for Emergency Medicine and Pulmonology, offering AI-powered detection of pleural effusion and consolidation/atelectasis, as well as cardiac conditions. EchoConfidence focuses exclusively on enhancing transthoracic echocardiogram analysis, making it ideal for cardiologists, critical care, and emergency medicine physicians who require automated measurements and assistance in report generation for cardiac diagnostics.

How do the AI capabilities of each tool contribute to diagnostic accuracy and reliability, especially considering real-time vs. post-acquisition analysis?

Lung AI offers real-time feedback and guided image capture, with AI-powered detection of lung and cardiac conditions, improving diagnostic accuracy for users of varying expertise. EchoConfidence provides automated analysis of over 100 echocardiogram measures and includes human-in-the-loop AI, which assists in reviewing images, making measurements, and writing reports, aiming to improve consistency and precision in cardiac measurements.

What is the expected learning curve for physicians to effectively utilize each tool's AI features, and how quickly can they expect to see clinical value?

Exo's Lung AI, integrated with the handheld Exo Iris device, includes 'Exo U' for AI-powered POCUS education and guided image capture, suggesting a focus on simplifying the learning process for point-of-care ultrasound users. EchoConfidence emphasizes clinical training and support, with specialists delivering in-depth, hands-on sessions to integrate the software into existing workflows, aiming to optimize reporting efficiency and diagnostic consistency.

How do these tools facilitate the integration of AI-derived findings and measurements into the electronic health record (EHR)?

For Lung AI, the on-device AI processing suggests that integration with EHRs would likely involve exporting data from the Exo Iris device, though specific EHR integration methods are not detailed. EchoConfidence is designed to assist in report generation and integrates with hospital systems via HL7 or PDF, facilitating the incorporation of automated measurements and structured reports into the EHR.

What are the key considerations for deploying these tools across multiple hospital sites, and are customer references available to demonstrate real-world implementation success?

Lung AI, being a handheld device with on-device AI, may offer flexibility for multi-site deployment by distributing devices, and Exo aims to make AI-empowered medical imaging accessible to every caregiver. EchoConfidence's deployment as software installed on hospital computers connected to imaging systems would require site-specific IT coordination, and Mycardium AI works with clinical teams to seamlessly integrate the software into daily practices, with customer references likely available through their clinical application specialists.